Connect
MJA
MJA

    Subsidised access to TNF-α inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?

    Erica L Mann
    Med J Aust 2005; 182 (1): . || doi: 10.5694/j.1326-5377.2005.tb06566.x
    Published online: 3 January 2005

    Erica L Mann

    • Erica L Mann

    • Wyeth Australia and New Zealand, 17-19 Solent Circuit, Norwest Business Park, Baulkham Hills, NSW 2153.

    Correspondence: 

    Author
    remove_circle_outline Delete Author
    add_circle_outline Add Author
    Comment
    Do you have any competing interests to declare? *
    I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
    I/we agree to the Terms of use of the Medical Journal of Australia *
    Email me when people comment on this article
    Online responses are no longer available. Please refer to our instructions for authors page for more information.